Endometrial Cancer

>

Latest News

Social Determinants of Health Negatively Affected Endometrial Cancer Diagnosis
Social Determinants of Health Negatively Affected Endometrial Cancer Diagnosis

March 19th 2025

Factors such as language spoken, social vulnerability index characteristics, and insurance type were found to alter endometrial cancer diagnoses and led to worse outcomes.

Patients who had recurrence in the radiation field experienced similar responses vs those with recurrence outside the radiation field.
Immunotherapy Sustains Responses in Radiated Endometrial/Cervical Cancer

March 18th 2025

The adverse effect profile of abemaciclib plus hormonal therapy was comparable with prior reports of CDK4/6 inhibitors.
Abemaciclib Plus Hormonal Therapy Shows Promising Efficacy in LGSOC/EEC

March 17th 2025

Selinexor Maintenance Improves PFS in TP53 Wild-Type Endometrial Cancer
Selinexor Maintenance Improves PFS in TP53 Wild-Type Endometrial Cancer

March 17th 2025

Puxitatug samrotecan was well tolerated in patients with advanced or metastatic endometrial cancer.
Puxitatug Samrotecan Exhibits Efficacy in Advanced/Metastatic EC

March 16th 2025

Video Series
Video Interviews
Podcasts
Ritu Salani, MD, highlights data from the RUBY trial supporting the FDA approval of dostarlimab/chemotherapy for primary advanced endometrial cancer.

More News